









市场行情
/
股票
/
nasdaq-osur
/

OraSure Technologies Inc

OSUR

2.400USD

-0.170-6.61%

收盘 11/06, 16:00（美东）报价延迟15分钟

173.44M总市值

亏损市盈率 TTM



OraSure Technologies Inc

2.400

-0.170-6.61%

概览公司财务分析

概览

公司

财务

分析

关于 OraSure Technologies Inc 公司

OraSure Technologies, Inc. 提供即时诊断和家庭诊断测试、样本管理解决方案以及微生物组实验室和分析服务。该公司的产品组合分为诊断产品和样本管理解决方案。其业务包括开发、制造、营销和销售使用其技术的诊断产品和标本收集设备，以及其他诊断产品，包括用于其他标本类型的免疫测定和其他体外诊断测试。其诊断产品包括在即时诊断快速进行的 COVID-19、HIV 和丙型肝炎等疾病测试，以及在实验室处理的滥用药物测试。其业务还包括临床实验室、直接面向消费者的实验室、研究人员、制药公司以及动物健康服务和产品提供商使用的分子样本管理解决方案和服务。

OraSure Technologies Inc简介



公司代码OSUR

公司名称OraSure Technologies Inc

上市日期Nov 17, 1986

CEOMs. Carrie Eglinton Manner

员工数量501

证券类型Ordinary Share

年结日Nov 17

公司地址220 E First St

城市BETHLEHEM

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编18015

电话15036416115

网址https://www.orasure.com/

公司代码OSUR

上市日期Nov 17, 1986

CEOMs. Carrie Eglinton Manner

OraSure Technologies Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Kenneth J. (Ken) Mcgrath

Chief Financial Officer

448.46K

-2.72%

Dr. Nancy J. Gagliano, M.D.

Independent Director

158.15K

+72.80%

Mr. John P. Kenny

Independent Chairman of the Board

153.32K

+4.16%

Mr. Lelio Marmora

Independent Director

130.76K

+93.09%

Hon Dr. David J. Shulkin, M.D.

Independent Director

126.33K

+109.45%

Ms. Anne Messing

Chief Commercial Officer

Mr. Steven Boyd ,

Independent Director

Mr. Robert W. Mcmahon

Independent Director

Mr. Jason Plagman

Vice President - Investor Relations

Ms. Carrie Eglinton Manner

President, Chief Executive Officer, Director

名称

名称/职务

职务

持股

持股变动

Mr. Kenneth J. (Ken) Mcgrath

Chief Financial Officer

448.46K

-2.72%

Dr. Nancy J. Gagliano, M.D.

Independent Director

158.15K

+72.80%

Mr. John P. Kenny

Independent Chairman of the Board

153.32K

+4.16%

Mr. Lelio Marmora

Independent Director

130.76K

+93.09%

Hon Dr. David J. Shulkin, M.D.

Independent Director

126.33K

+109.45%

Ms. Anne Messing

Chief Commercial Officer

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Net product and services revenues - COVID-19

14.40M

46.09%

Net product and services revenues - HIV

9.86M

31.54%

Net product and service revenues -Molecular Products

4.13M

13.21%

Other revenues - Other non Product revenues

1.40M

4.47%

Net product and services revenues - Risk assessment testing

994.00K

3.18%

其他

474.00K

1.52%

地区USD

名称

营收

占比

United States

19.85M

63.54%

Africa (Region)

8.03M

25.69%

Europe

2.12M

6.78%

Other Regions

1.25M

3.99%

业务

地区

业务USD

名称

营收

占比

Net product and services revenues - COVID-19

14.40M

46.09%

Net product and services revenues - HIV

9.86M

31.54%

Net product and service revenues -Molecular Products

4.13M

13.21%

Other revenues - Other non Product revenues

1.40M

4.47%

Net product and services revenues - Risk assessment testing

994.00K

3.18%

其他

474.00K

1.52%

股东统计

更新时间: 8月19日周二

持股股东

股东类型

持股股东

占比

Private Management Group, Inc.

7.61%

BlackRock Institutional Trust Company, N.A.

7.58%

The Vanguard Group, Inc.

5.81%

Neuberger Berman, LLC

5.79%

Altai Capital Management, L.P.

5.23%

其他

67.98%

持股股东

占比

Private Management Group, Inc.

7.61%

BlackRock Institutional Trust Company, N.A.

7.58%

The Vanguard Group, Inc.

5.81%

Neuberger Berman, LLC

5.79%

Altai Capital Management, L.P.

5.23%

其他

67.98%

股东类型

持股股东

占比

Investment Advisor

40.12%

Investment Advisor/Hedge Fund

27.45%

Hedge Fund

21.36%

Individual Investor

5.12%

Research Firm

2.35%

Pension Fund

0.44%

Bank and Trust

0.30%

Venture Capital

0.09%

Insurance Company

0.04%

其他

2.73%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

451

67.31M

92.04%

-15.49M

2025Q2

473

72.08M

98.55%

-16.70M

2025Q1

483

70.23M

93.78%

-12.52M

2024Q4

475

70.81M

94.94%

-10.37M

2024Q3

471

70.30M

94.28%

-10.80M

2024Q2

477

73.05M

98.74%

-8.54M

2024Q1

473

74.45M

97.36%

-5.59M

2023Q4

464

73.29M

99.74%

-5.62M

2023Q3

456

72.50M

98.73%

-4.51M

2023Q2

452

70.73M

96.51%

-2.77M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Private Management Group, Inc.

5.46M

7.47%

+1.04M

+23.64%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.43M

7.43%

-141.00K

-2.53%

Jun 30, 2025

The Vanguard Group, Inc.

4.17M

5.7%

-120.08K

-2.80%

Jun 30, 2025

Neuberger Berman, LLC

4.16M

5.68%

-124.14K

-2.90%

Jun 30, 2025

Altai Capital Management, L.P.

3.75M

5.13%

+1.59M

+73.37%

Sep 02, 2025

Dimensional Fund Advisors, L.P.

3.84M

5.25%

+14.96K

+0.39%

Jun 30, 2025

Renaissance Technologies LLC

2.28M

3.11%

-294.84K

-11.47%

Jun 30, 2025

Systematic Financial Management, L.P.

2.23M

3.05%

+581.93K

+35.33%

Jun 30, 2025

Acadian Asset Management LLC

2.19M

-563.24K

-20.44%

Jun 30, 2025

American Century Investment Management, Inc.

2.08M

2.85%

-423.60K

-16.91%

Jun 30, 2025

持股ETF



更新时间: 22 小时前

机构名称

占比

Invesco NASDAQ Future Gen 200 ETF

0.47%

iShares US Small Cap Value Factor ETF

0.38%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.07%

iShares Micro-Cap ETF

0.05%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.05%

Avantis US Small Cap Equity ETF

0.03%

WisdomTree US SmallCap Fund

0.03%

iShares US Small-Cap Equity Factor ETF

0.02%

iShares Russell 2000 Value ETF

0.02%

ProShares UltraPro Russell2000

0.01%

Invesco NASDAQ Future Gen 200 ETF

占比0.47%

iShares US Small Cap Value Factor ETF

占比0.38%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

占比0.07%

iShares Micro-Cap ETF

占比0.05%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.05%

Avantis US Small Cap Equity ETF

占比0.03%

WisdomTree US SmallCap Fund

占比0.03%

iShares US Small-Cap Equity Factor ETF

占比0.02%

iShares Russell 2000 Value ETF

占比0.02%

ProShares UltraPro Russell2000

占比0.01%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

KeyAI

